Two-week central macular thickness reduction rate >37% predicts the long-term efficacy of anti-vascular endothelial growth factor treatment for macular edema secondary to retinal vein occlusion

HIGHLIGHTS

• who: Danning Liu from the Department of, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China have published the research: Two-Week Central Macular Thickness Reduction Rate >37% Predicts the Long-Term Efficacy of Anti-vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion, in the Journal: (JOURNAL)
• what: The study has found other baseline indexes that are correlated with long-term efficacy following anti-VEGF treatment. The study has a relatively short-term follow-up time and a small sample size.
• how: The anti-VEGF agents used in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.